Lexagene Holdings Inc V.LXG

Primary Symbol: LXXGQ

Healthcare Medical Devices

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.

GREY:LXXGQ - Post by User

Lexagene Holdings Inc > Direct email from Daryl Rebeck

<< Previous

Bullboard Posts

Next >>

Comment by Investor62on Apr 04, 2020 10:29am

105 Views

Post# 30878795

RE:RE:RE:RE:Direct email from Daryl Rebeck

No idea if the letter is true or not but the content is nothing really new:
Their inital and primary target was Vet and Food as this does not require much paperwork for approval while healtcare is much more regulated. Now with the urgency of COVID-19 there is a good change to get much quicker to a EUA clearance. This has been given to the larger companies very quickly – now LXG is working with Steven Armstrong, the new Senior Director of Operations, their new leadership which brings experience achieving FDA clearance.
The main question now is how long it takes for LXG to get the FDA clearence for LX2.

<< Previous

Bullboard Posts

Next >>

Canadian artificial intelligence ETFs